These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


647 related items for PubMed ID: 27807169

  • 1. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
    Li W, Allen ME, Rui Y, Ku L, Liu G, Bankston AN, Zheng JQ, Feng Y.
    J Neurosci; 2016 Nov 02; 36(44):11283-11294. PubMed ID: 27807169
    [Abstract] [Full Text] [Related]

  • 2. p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.
    Bankston AN, Li W, Zhang H, Ku L, Liu G, Papa F, Zhao L, Bibb JA, Cambi F, Tiwari-Woodruff SK, Feng Y.
    J Biol Chem; 2013 Jun 21; 288(25):18047-57. PubMed ID: 23645679
    [Abstract] [Full Text] [Related]

  • 3. The Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination.
    Luo F, Zhang J, Burke K, Miller RH, Yang Y.
    J Neurosci; 2016 Mar 09; 36(10):3024-37. PubMed ID: 26961956
    [Abstract] [Full Text] [Related]

  • 4. Peripheral and orofacial pain sensation is unaffected by the loss of p39.
    Prochazkova M, Hall B, Hu M, Okine T, Reukauf J, Binukumar BK, Amin ND, Roque E, Pant HC, Kulkarni A.
    Mol Pain; 2017 Mar 09; 13():1744806917737205. PubMed ID: 28969475
    [Abstract] [Full Text] [Related]

  • 5. Cyclin-Dependent Kinase 5 Regulates Dendritic Spine Formation and Maintenance of Cortical Neuron in the Mouse Brain.
    Mita N, He X, Sasamoto K, Mishiba T, Ohshima T.
    Cereb Cortex; 2016 Mar 09; 26(3):967-976. PubMed ID: 25404468
    [Abstract] [Full Text] [Related]

  • 6. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.
    Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH.
    J Neurosci; 2001 Sep 01; 21(17):6758-71. PubMed ID: 11517264
    [Abstract] [Full Text] [Related]

  • 7. Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses.
    Johansson JU, Lilja L, Chen XL, Higashida H, Meister B, Noda M, Zhong ZG, Yokoyama S, Berggren PO, Bark C.
    Brain Res Mol Brain Res; 2005 Aug 18; 138(2):215-27. PubMed ID: 15908038
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.
    Asada A, Saito T, Hisanaga S.
    J Cell Sci; 2012 Jul 15; 125(Pt 14):3421-9. PubMed ID: 22467861
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.
    Hallows JL, Chen K, DePinho RA, Vincent I.
    J Neurosci; 2003 Nov 19; 23(33):10633-44. PubMed ID: 14627648
    [Abstract] [Full Text] [Related]

  • 15. Preferential targeting of p39-activated Cdk5 to Rac1-induced lamellipodia.
    Ito Y, Asada A, Kobayashi H, Takano T, Sharma G, Saito T, Ohta Y, Amano M, Kaibuchi K, Hisanaga S.
    Mol Cell Neurosci; 2014 Jul 19; 61():34-45. PubMed ID: 24877974
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.
    Maccioni RB, Otth C, Concha II, Muñoz JP.
    Eur J Biochem; 2001 Mar 19; 268(6):1518-27. PubMed ID: 11248668
    [Abstract] [Full Text] [Related]

  • 18. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S, Saito T.
    Neurosignals; 2003 Mar 19; 12(4-5):221-9. PubMed ID: 14673209
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system.
    Zheng M, Leung CL, Liem RK.
    J Neurobiol; 1998 May 19; 35(2):141-59. PubMed ID: 9581970
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.